Stelzer Laurie 4
4 · Spyre Therapeutics, Inc. · Filed Nov 27, 2023
Insider Transaction Report
Form 4
Stelzer Laurie
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-11-22+50,000→ 50,000 totalExercise: $10.39Exp: 2033-11-22→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 50,000 shares of the Issuer's common stock, which will vest and become exercisable in 36 equal monthly installments beginning on November 22, 2023 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.